68Ga-labeled nanobody (68Ga-NC-BCH) is a single-domain antibody–based PET imaging agent. We conducted a first-in-humans study of 68Ga-NC-BCH for PET to determine its in vivo biodistribution, ...

Radiopharmaceutical therapy (RPT) is entering a new era of personalization, driven by advances in molecular imaging, radiopharmaceutical development, and a growing body of clinical evidence linking ...

Fibroblast activation protein (FAP), a member of the serine protease family, is expressed in the microenvironment of more than 90% of epithelial tumors, including pancreas, colon, breast, and ENT (ear ...

The linear no-threshold (LNT) model for radiation-induced cancer was adopted by national and international advisory bodies in the 1950s and has guided radiation protection policies worldwide since ...

Parkinsonian disorders have clinically similar features characterized by akinesia with resting tremor, rigidity, or postural instability (1) but exhibit pathologically distinct features (2).

Aberrantly expressed glycans on mucins such as mucin-16 (MUC16) are implicated in the biology that promotes ovarian cancer (OC) malignancy. Here, we investigated the theranostic potential of a ...

In the past decade, an increasing number of approved therapies with various mechanisms of action have become available for metastatic castration-resistant prostate cancer (mCRPC), but the associated ...

Journal of Nuclear Medicine August 2026, jnumed.126.272179; DOI: https://doi.org/10.2967/jnumed.126.272179 ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

Journal of Nuclear Medicine July 2026, jnumed.126.272647; DOI: https://doi.org/10.2967/jnumed.126.272647 ...

Journal of Nuclear Medicine June 2026, jnumed.125.271392; DOI: https://doi.org/10.2967/jnumed.125.271392 ...

Journal of Nuclear Medicine July 2026, jnumed.126.272545; DOI: https://doi.org/10.2967/jnumed.126.272545 ...